Accessible AR Opportunity Cognixion specializes in assisted reality with noninvasive BCI, targeting speech-impaired populations and healthcare providers; ideal for sales outreach to hospitals, rehab centers, speech-language pathology clinics, and long-term care facilities seeking empowering communication solutions.

ALS and Neurotech Trials Recent trial launches for BCI with AI apps for ALS indicate active engagement in clinical deployments and patient-focused R&D partnerships; prioritize conversations with research hospitals, neurology departments, and patient advocacy groups seeking innovative assistive technologies.

Strategic Partnerships Partnership with Blackrock Neurotech and compatibility with AI-enabled interfaces position Cognixion for co-selling or integration deals; explore OEM, system integrator, or collaboration opportunities with neurotech firms, device distributors, and AR/BCI platforms.

Regulatory Momentum FDA Breakthrough Device designation previously awarded signals regulatory advancement and faster path to market; leverage this to pitch near-term commercialization plans to healthcare purchasers and insurers seeking innovative, approved assistive devices.

Global and AI Enablement Recognized globally with awards and TIME Best Inventions listing, plus AI-driven AR/BCI capabilities and cross-border presence in Santa Barbara and Toronto; target multinational healthcare systems, telehealth providers, and education markets looking for scalable assistive tech with AI integration.